Top

Published in:

01-08-2018 | Letter to the Editor

Reply to the letter: “Can such an animal model truly represent Henoch–Schönlein purpura?”

Authors: Yanhong Li, Xiaolong Sui, Hua Zhu, Yanfeng Xu, Lan Huang, Yuhuan Xu, Yunlin Han, Xiaochun Feng, Chuan Qin

Published in: Archives of Dermatological Research | Issue 6/2018

Excerpt

First of all, we would like to explain that animal models are made to simulate a part or most of the characteristics of human disease, which does not fully represent human disease, and make it easier for workers to refer and utilize in a certain aspect. We are very pleased with the attention and advice of the HSP animal model. We will actively improve it, and hope all of us will work together to make animal resources better serve the clinical and scientific research. …

Chen WF, Jin BQ (2004) Medical immunology. People’s Medical Publishing House, Beijing

Emancipator SN, Lamm ME (1989) Biology of disease: IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest 60:168–183PubMed

Hisano S, Matsushita M, Fujita T, Iwasak H (2005) Activation of the lectin complement pathway in Henoch–Schönlein purpuranephritis. Am J Kidney Dis 45:295–302CrossRefPubMed

Kondo N, Kasahara K, Shinoda S, Orii T (1992) Accelerated expression of secreted α-chain gene in anaphylactoid purpura. J Clin Immunol 12:193–196CrossRefPubMed

Li Y, Sui X, Zhu H, Xu Y, Huang L, Xu Y, Han Y, Feng X, Qin C (2017) Histopathological and immunological changes during the acute and recovery phase in Henoch–Schönlein purpura rabbit model. Arch Dermatol Res 309:21–30CrossRefPubMed

Reamy BV, Williams PM, Lindsay TJ (2009) Henoch–Schönlein purpura. Am Fam Physician 80:697–704PubMed

Todd DJ, Helfgott SM (2007) Serum sickness following treatment with rituximab. J Rheumatol 34:430–433PubMed

Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL (2000) Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch–Schönlein purpura. Clin Exp Immunol 122:285–290CrossRefPubMedPubMedCentral

Title: Reply to the letter: “Can such an animal model truly represent Henoch–Schönlein purpura?”
Authors: Yanhong Li
Xiaolong Sui
Hua Zhu
Yanfeng Xu
Lan Huang
Yuhuan Xu
Yunlin Han
Xiaochun Feng
Chuan Qin
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Archives of Dermatological Research / Issue 6/2018
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-018-1839-3

At a glance: The STEP trials

Springer Medicine

Reply to the letter: “Can such an animal model truly represent Henoch–Schönlein purpura?”

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

Amelioration of lactic acid sensations in sensitive skin by stimulating the barrier function and improving the ceramide profile

Up-regulation of HMGB1 and TLR4 in skin lesions of lichen planus

Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data

Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review

Can such an animal model truly represent Henoch–Schönlein purpura?

CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study